Australasian Diabetes in Pregnancy Society (ADIPS) 2025 consensus recommendations for the screening, diagnosis and classification of gestational diabetes
- PMID: 40544364
- PMCID: PMC12318493
- DOI: 10.5694/mja2.52696
Australasian Diabetes in Pregnancy Society (ADIPS) 2025 consensus recommendations for the screening, diagnosis and classification of gestational diabetes
Abstract
Introduction: In the context of a global obesity and diabetes epidemic, gestational diabetes mellitus and other forms of hyperglycaemia in pregnancy are increasingly common. Hyperglycaemia in pregnancy is associated with short and long term complications for both the woman and her baby. These 2025 consensus recommendations from the Australasian Diabetes in Pregnancy Society (ADIPS) update the guidance for the screening, diagnosis and classification of hyperglycaemia in pregnancy based on available evidence and stakeholder consultation.
Main recommendations: Overt diabetes in pregnancy (overt DIP) should be diagnosed at any time in pregnancy if one or more of the following criteria are met: (i) fasting plasma glucose (FPG) ≥ 7.0 mmol/L; (ii) two-hour plasma glucose (2hPG) ≥ 11.1 mmol/L following a 75 g two-hour pregnancy oral glucose tolerance test (POGTT); and/or (iii) glycated haemoglobin (HbA1c) ≥ 6.5% (≥ 48 mmol/mol). Irrespective of gestation, gestational diabetes mellitus should be diagnosed using one or more of the following criteria during a 75 g two-hour POGTT: (i) FPG ≥ 5.3-6.9 mmol/L; (ii) one-hour plasma glucose (1hPG) ≥ 10.6 mmol/L; (iii) 2hPG ≥ 9.0-11.0 mmol/L. Women with risk factors for hyperglycaemia in pregnancy should be advised to have the HbA1c measured in the first trimester. Women with HbA1c ≥ 6.5% (≥ 48 mmol/mol) should be diagnosed and managed as having overt DIP. Before 20 weeks' gestation, and ideally between ten and 14 weeks' gestation, if tolerated, women with a previous history of gestational diabetes mellitus or early pregnancy HbA1c ≥ 6.0-6.4% (≥ 42-47 mmol/mol), but without diagnosed diabetes, should be advised to undergo a 75 g two-hour POGTT. All women (without diabetes already detected in the current pregnancy) should be advised to undergo a 75 g two-hour POGTT at 24-28 weeks' gestation.
Changes in management as a result from this consensus statement: These updated recommendations raise the diagnostic glucose thresholds for gestational diabetes mellitus and clarify approaches to early pregnancy screening for women with risk factors for hyperglycaemia in pregnancy.
Keywords: Diabetes; Diabetes complications; Diabetes mellitus, type 1; Diabetes mellitus, type 2; Diagnostic tests and procedures; Mass screening; Pregnancy; Pregnancy complications; Pregnancy in diabetics; gestational; high‐risk.
© 2025 The Author(s). Medical Journal of Australia published by John Wiley & Sons Australia, Ltd on behalf of AMPCo Pty Ltd.
Conflict of interest statement
Matthew Hare has received honoraria for lectures and consultancies from AstraZeneca, Boehringer Ingelheim, Eli Lilly and Novo Nordisk. Rosemary Hall has received speaking honoraria from Novo Nordisk, Sanofi, Eli Lilly and Dexcom, and served on the New Zealand Diabetes Advisory Boards for Boehringer Ingelheim, Dexcom, Abbott and Novo Nordisk. David Simmons has received honoraria for lectures and consultancies from Novo Nordisk, Ascensia, Abbott and Sanofi, educational grants from Boehringer Ingelheim and Asensia, and equipment from Roche. The Australasian Diabetes in Pregnancy Society has received industry sponsorship for conferences and research grants.
Similar articles
-
Preexisting Diabetes and Pregnancy: An Endocrine Society and European Society of Endocrinology Joint Clinical Practice Guideline.Eur J Endocrinol. 2025 Jun 30;193(1):G1-G48. doi: 10.1093/ejendo/lvaf116. Eur J Endocrinol. 2025. PMID: 40652450
-
Different intensities of glycaemic control for women with gestational diabetes mellitus.Cochrane Database Syst Rev. 2023 Oct 10;10(10):CD011624. doi: 10.1002/14651858.CD011624.pub3. Cochrane Database Syst Rev. 2023. PMID: 37815094 Free PMC article.
-
Different intensities of glycaemic control for women with gestational diabetes mellitus.Cochrane Database Syst Rev. 2016 Apr 7;4(4):CD011624. doi: 10.1002/14651858.CD011624.pub2. Cochrane Database Syst Rev. 2016. Update in: Cochrane Database Syst Rev. 2023 Oct 10;10:CD011624. doi: 10.1002/14651858.CD011624.pub3. PMID: 27055233 Free PMC article. Updated.
-
Different strategies for diagnosing gestational diabetes to improve maternal and infant health.Cochrane Database Syst Rev. 2017 Aug 23;8(8):CD007122. doi: 10.1002/14651858.CD007122.pub4. Cochrane Database Syst Rev. 2017. PMID: 28832911 Free PMC article.
-
Techniques of monitoring blood glucose during pregnancy for women with pre-existing diabetes.Cochrane Database Syst Rev. 2017 Jun 11;6(6):CD009613. doi: 10.1002/14651858.CD009613.pub3. Cochrane Database Syst Rev. 2017. Update in: Cochrane Database Syst Rev. 2019 May 23;5:CD009613. doi: 10.1002/14651858.CD009613.pub4. PMID: 28602020 Free PMC article. Updated.
References
-
- Report of a World Health Organization Consultation: diagnostic criteria and classification of hyperglycaemia first detected in pregnancy: a World Health Organization guideline. Diabetes Res Clin Pract 2014; 103: 341‐363. - PubMed
-
- Sweeting A, Wesley H, Backman H, et al. Epidemiology and management of gestational diabetes. Lancet 2024; 404: 175‐192. - PubMed
-
- HAPO Study Cooperative Research Group ; Metzger BE, Lowe LP, Dyer AR, et al. Hyperglycemia and adverse pregnancy outcomes. New Eng J Med 2008; 358: 1991‐2002. - PubMed
-
- Bardugo et al. Glucose intolerance in pregnancy and risk of early‐onset type 2 diabetes: a population‐based cohort study. Lancet Diabetes Endocrinol 2023; 11: 333‐344. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous